Meridian Bioscience Inc.

NASDAQ: VIVO · Real-Time Price · USD
33.97
0.00 (0.00%)
At close: Jan 30, 2023, 10:00 PM

Meridian Bioscience Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net Income
-29.82M 5.71M -7.34M 28.75M 15.34M 6.66M 11.67M 26.3M 26.78M
Depreciation & Amortization
4.18M 4.07M 4.11M 4.15M 4.18M 4.1M 3.75M 3.71M 1.51M
Stock-Based Compensation
1.39M 1.89M 1.62M 1.49M 1.9M 986K 879K 1.05M 1.24M
Other Working Capital
29.93M 1.93M -7.93M 3.7M 1.31M 242K -3.02M -7.97M 6.71M
Other Non-Cash Items
n/a -1.88M 10.21M 71K -646K 4.06M -4.05M -2.96M 3.27M
Deferred Income Tax
216K -3.35M 802K 519K 927K -3.8M 742K 75K -852K
Change in Working Capital
21.68M -4.45M 5M -4.56M 13.85M 2.47M -2.1M -11.8M -6.83M
Operating Cash Flow
-2.35M 1.99M 14.4M 30.42M 35.55M 14.48M 10.89M 16.37M 25.12M
Capital Expenditures
-2.65M -3.48M -1.96M -1.47M -1.71M -1.91M -4.45M -9.87M -2.09M
Cash Acquisitions
n/a n/a -3.75M n/a n/a -18.59M n/a n/a -5M
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-2M 1.25M n/a n/a n/a 1.5M n/a n/a n/a
Investing Cash Flow
-4.65M -2.23M -5.71M -1.47M -1.71M -18.99M -4.45M -9.87M -7.09M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-2.52M 33.83M 1.64M -24.38M -11.09M -15.18M 87K -5.97M -10M
Financial Cash Flow
-2.52M -472K 1.64M -24.38M -11.09M -15.18M 87K -5.97M -10M
Net Cash Flow
-7.36M -2.03M 7M 3.76M 22.96M -20.24M 6.64M 181K 9.68M
Free Cash Flow
-5M -1.49M 12.44M 28.95M 33.85M 12.57M 6.44M 6.5M 23.04M